CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- 4 Planned sale President and CEO sold 970 shares at $6.69 ($6,489)
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Grant or award Chief Financial Officer acquired 16,665 shares (grant or award)
- 4 Grant or award President and CEO acquired 213,785 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale President and CEO sold 10,321 shares at $7.16 ($73,898)
- 4 Planned sale Chief Financial Officer sold 5,039 shares at $7.16 ($36,079)
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale Chief Financial Officer sold 80 shares at $7.86 ($629)
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Planned sale Director sold 592 shares at $9.14 ($5,411)
- 4 Planned sale President and CEO sold 393 shares at $9.14 ($3,592)
- 4 Planned sale Director sold 283 shares at $9.14 ($2,587)
- 4 Planned sale President and CEO sold 4,000 shares at an average $10.04 ($40,140)
- 144/A Insider Sale of Securities
- 4 Planned sale President and CEO sold 6,000 shares at an average $10.45 ($62,720)
Page 4 of 53 · 1,058 filings